131 related articles for article (PubMed ID: 31364053)
21. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype.
Murray JS; Pfeiffer C; Madri J; Bottomly K
Eur J Immunol; 1992 Feb; 22(2):559-65. PubMed ID: 1347015
[TBL] [Abstract][Full Text] [Related]
22. MHC molecules and lymphocytes: evolutionary perspective.
Płytycz B; Seljelid R
Arch Immunol Ther Exp (Warsz); 1998; 46(3):137-42. PubMed ID: 9704145
[TBL] [Abstract][Full Text] [Related]
23. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
24. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
25. Contribution of mass spectrometry-based proteomics to immunology.
Hillen N; Stevanovic S
Expert Rev Proteomics; 2006 Dec; 3(6):653-64. PubMed ID: 17181480
[TBL] [Abstract][Full Text] [Related]
26. Development of a semi-automated MHC-associated peptide proteomics (MAPPs) method using streptavidin bead-based immunoaffinity capture and nano LC-MS/MS to support immunogenicity risk assessment in drug development.
Lee MV; Saad OM; Wong S; LaMar J; Kamen L; Ordonia B; Melendez R; Hassanzadeh A; Chung S; Kaur S
Front Immunol; 2023; 14():1295285. PubMed ID: 38022649
[TBL] [Abstract][Full Text] [Related]
27. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
Kuznetsov A; Voronina A; Govorun V; Arapidi G
Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004
[TBL] [Abstract][Full Text] [Related]
28. Chicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides.
Cumberbatch JA; Brewer D; Vidavsky I; Sharif S
Anim Genet; 2006 Aug; 37(4):393-6. PubMed ID: 16879355
[TBL] [Abstract][Full Text] [Related]
29. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
30. Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.
Herr W; Ranieri E; Gambotto A; Kierstead LS; Amoscato AA; Gesualdo L; Storkus WJ
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12033-8. PubMed ID: 10518571
[TBL] [Abstract][Full Text] [Related]
31. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
Baum H; Staines NA
Cytokines Cell Mol Ther; 1997 Jun; 3(2):115-25. PubMed ID: 9287250
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
Afridi S; Hoessli DC; Hameed MW
Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
[TBL] [Abstract][Full Text] [Related]
33. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
34. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
35. MHC-bound antigens and proteomics for novel target discovery.
Shoshan SH; Admon A
Pharmacogenomics; 2004 Oct; 5(7):845-59. PubMed ID: 15469407
[TBL] [Abstract][Full Text] [Related]
36. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
37. Identification of peptides associated with chicken major histocompatibility complex class II molecules of B21 and B19 haplotypes.
Haeri M; Read LR; Wilkie BN; Sharif S
Immunogenetics; 2005 Feb; 56(11):854-9. PubMed ID: 15650875
[TBL] [Abstract][Full Text] [Related]
38. Identification of Human Antigen-Specific CD4
Kong YY; Kwok WW
Methods Mol Biol; 2019; 1988():375-386. PubMed ID: 31147953
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
